Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04625673 · ClinicalTrials.gov registry record · NA
OsciPulse Device for the Prevention of VTE
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 23
- Enrollment target
NCT04625673: Completed NA study, sponsored by University of Pennsylvania.
NCT04625673 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 23 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04625673, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 23 participants
- Enrollment target
Study Summary
This is a Phase 2 safety and tolerability trial that will take place in two parts. Part one of the trial will determine the tolerability of the OsciPulse device on healthy subjects who wear the device for up to three hours. Healthy volunteers will answer questionnaires and may undergo an ultrasound test at the end of their participation in the trial. Part two of the trial will determine the safety and tolerability of the OsciPulse device on subjects admitted to Penn Presbyterian Medical Center. Eligible subjects will be enrolled for 6 hours. In the first 3 hours, subjects will wear the standard of care intermittent pneumatic compression device or the OsciPulse device. In the second 3 hours, the subject's device will be switched and subjects will wear the alternate device not used in the first 3 hours. Subjects will answer questionnaires and may undergo an ultrasound at the end of the first 3 hours and at the end of the second 3 hours (at hour 6).
Interventions
- DEVICE OsciPulse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2021-05-12 |
| Est. Completion | 2022-10-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04625673
The ClinicalTrials.gov registry entry for NCT04625673 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which OsciPulse is the first listed.
NCT04625673 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04625673 about?
NCT04625673 is a clinical study titled "OsciPulse Device for the Prevention of VTE". This is a Phase 2 safety and tolerability trial that will take place in two parts. Part one of the trial will determine the tolerability of the OsciPulse device on healthy subjects who wear the device for up to three hours. Healthy volunteers will answer questionnaires and may undergo an ultrasound ...
What is the current status of trial NCT04625673?
This trial is currently completed. It is a NA study. The enrollment target is 23 participants. The study started on 2021-05-12. Estimated completion is 2022-10-15.
What interventions are being tested in trial NCT04625673?
The interventions under investigation include: OsciPulse (DEVICE).
Who is sponsoring clinical trial NCT04625673?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.